Main Catalog

Found 70
Sort by
AMCP Annual Meeting
Member Free
Non-Member $30.00

Measuring Value of an IDN Specialty Pharmacy Therapy Management Program for Biologics

Contact Hours: 1.25: Gene therapy is a promising treatment option for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections. The first gene therapy approvals in the United States occurred in 2017.
Specialty
Nexus Conferences
Member Free
Non-Member $30.00

Medical Benefit Medication Management - Low Hanging Fruit to Complex Strategy - Nexus 2017

Contact Hours: 1.5. Are you up to speed on the latest industry best practices in managing your medical-benefit medications?
Hospital/Health Systems
Nexus Conferences
Member Free
Non-Member $30.00

Medical Oncology Drug Cost Trends and Innovative, Practical Payer Management Strategies - Nexus 2018

Contact Hours: 1.5. Medical oncology drugs represent 35 to 47% percent of total medical benefit drug spend.
Oncology
AMCP Annual Meeting
Member Free
Non-Member $30.00

Medicare Formulary Updates Impact

Contact Hours: 1.25. The Centers for Medicare and Medicaid (CMS) continues to critically evaluate formulary regulations and guidance to help lower drug costs.
Medicare
AMCP Annual Meeting
Member Free
Non-Member $30.00

More than Meets the Eye–Value-Based Contracts are More Prevalent than We Think

Contact Hours: 1.25. As the U.S. health care system evolves from a volume-driven system to one that rewards value, there is growing interest in value-based payment arrangements.
Value-Based Contracting
AMCP Annual Meeting
Member Free
Non-Member $30.00

Patient Review and Restriction Programs: Prescription Drug Monitoring Programs and the Need for Collaboration

Contact Hours: 1.25. Patient Review and Restriction (PRR) programs are commonly used by health plans in doctor’s offices to manage the excessive prescribing of controlled substances or services.
Hospital/Health Systems
Nexus Conferences
Member Free
Non-Member $30.00

Payer & Manufacturer Communications: What’s Changed & How Does it Impact Managed Care Pharmacy? - Nexus 2017

Contact Hours: 1.5. FDA released long-awaited draft guidance clarifying the Provisions of FDAMA 114 as updated by Cures 3037, and also outlined its current thinking around preapproval information exchange (PIE).
CMS
AMCP Annual Meeting
Member $15.00
Non-Member $30.00

Perspectives in Gene Therapy Management - Annual Meeting 2019

Contact Hours: 1.0. The potential for gene therapy to transform the treatment of a wide variety of health conditions has important implications for many stakeholders.
Gene Therapy
Nexus Conferences
Member $15.00
Non-Member $30.00

Preventative Treatment for Alzheimer’s Disease and the Future Role of Value-Based Payment Arrangements

Contact Hours: 1.5. The current understanding of Alzheimer’s disease is evolving.
Alzheimer's
AMCP Annual Meeting
Member Free
Non-Member $30.00

Pulmonary Arterial Hypertension and the Managed Care Considerations for Formulary Decision-Making

Contact Hours: 1.25. Patients with pulmonary arterial hypertension (PAH) currently have a 60% five-year survival outlook, which has been increasing since the 1980s when it was a 37% five-year outlook.
Pulmonary Arterial Hypertension